FH
Publicaties op Oncologisch.com
Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olapari...
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall surv...
Olaparib-rechallenge als onderhoud bij recidief ovariumcarcinoom na eerdere PARP: OReO/ENGOT-ov38 langetermijn
Management van borderline ovariumtumoren: overzicht